EMBJ
Embraer S.A.
Embraer is a global aerospace company headquartered in Brazil. It manufactures aircraft for Commercial and Executive aviation, Defense & Security, and Agricultural customers. The company also provides after-sales services & support through a worldwide network of wholly owned entities and authorized agents. Since it was founded in 1969, Embraer has delivered more than 9,000 aircraft. On average, about every 10 seconds, an aircraft manufactured by Embraer takes off somewhere worldwide, transporting over 150 million passengers a year. Embraer is the leading manufacturer of commercial jets with up to 150 seats and is the leading exporter of high-value-added goods in Brazil. The company maintains industrial units, offices, service and parts distribution centers across the Americas, Africa, Asia, and Europe. SOURCE Avelo Airlines
Price sits at 53% of its 52-week range.
Current Price
$63.62
+1.61%GoodMoat Value
$55.43
12.9% overvaluedEmbraer S.A. (EMBJ) Quality Analysis
EMBJ Profitability
EMBJ Growth
EMBJ Financial Health
EMBJ Quality & Fundamental Analysis
Embraer S.A. (EMBJ) is a Industrials company in the Aerospace & Defense industry, listed on NYSE. This quality analysis page evaluates Embraer S.A.'s financial health using the Piotroski F-Score methodology, profitability ratios, growth trajectory, and balance sheet strength.
Embraer S.A. has a Piotroski F-Score of N/A out of 9, measuring profitability, leverage, and operating efficiency. The company operates with a profit margin of 4.64% and a return on equity (ROE) of 10.22%. Return on assets (ROA) stands at 2.72%.
The debt-to-equity ratio is 0.79, with a current ratio of 1.50. Operating margin is 6.68%.
GoodMoat's quality analysis uses AI-powered insights to evaluate whether Embraer S.A. is a fundamentally sound investment. The GoodMoat Verdict synthesizes profitability, growth, and financial health scores into a clear investment quality rating. Use these metrics alongside valuation tools like the DCF calculator and fair value models to make informed investment decisions.